Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001432243 | SCV001635007 | likely benign | Tuberous sclerosis 2 | 2020-10-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258921 | SCV002533962 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-03 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002258921 | SCV002635289 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |